151 related articles for article (PubMed ID: 21250721)
1. A strategy for the late-stage divergent syntheses of scyphostatin analogues.
Cha JY; Burnett GL; Huang Y; Davidson JB; Pettus TR
J Org Chem; 2011 Mar; 76(5):1361-71. PubMed ID: 21250721
[TBL] [Abstract][Full Text] [Related]
2. Short and efficient route to the fully functionalized polar core of scyphostatin.
Pitsinos EN; Cruz A
Org Lett; 2005 May; 7(11):2245-8. PubMed ID: 15901180
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Scyphostatin Analogues through Hypervalent Iodine-Mediated Phenol Dearomatization.
El Assal M; Peixoto PA; Coffinier R; Garnier T; Deffieux D; Miqueu K; Sotiropoulos JM; Pouységu L; Quideau S
J Org Chem; 2017 Nov; 82(22):11816-11828. PubMed ID: 28991470
[TBL] [Abstract][Full Text] [Related]
4. A furan Diels-Alder cycloaddition approach to scyphostatin analogues.
Fraser CJ; Howell GP; Harrity JP
Org Biomol Chem; 2012 Dec; 10(45):9058-66. PubMed ID: 23086598
[TBL] [Abstract][Full Text] [Related]
5. Synthesis (and alternative proof of configuration) of the scyphostatin C(1')-C(20') trienoyl fragment.
Hoye TR; Tennakoon MA
Org Lett; 2000 May; 2(10):1481-3. PubMed ID: 10814478
[TBL] [Abstract][Full Text] [Related]
6. Dynamic kinetic resolution during a vinylogous Payne rearrangement: a concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin.
Hoye TR; Jeffrey CS; Nelson DP
Org Lett; 2010 Jan; 12(1):52-5. PubMed ID: 19968321
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective total synthesis of (+)-Scyphostatin via a pi-facially selective Diels-Alder reaction.
Takagi R; Miyanaga W; Tojo K; Tsuyumine S; Ohkata K
J Org Chem; 2007 May; 72(11):4117-25. PubMed ID: 17477576
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
9. Total synthesis of (+)-scyphostatin featuring an enantioselective and highly efficient route to the side-chain via Zr-catalyzed asymmetric carboalumination of alkenes (ZACA).
Pitsinos E; Athinaios N; Xu Z; Wang G; Negishi E
Chem Commun (Camb); 2010 Apr; 46(13):2200-2. PubMed ID: 20234905
[TBL] [Abstract][Full Text] [Related]
10. Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment.
Izuhara T; Katoh T
Org Lett; 2001 May; 3(11):1653-6. PubMed ID: 11405678
[TBL] [Abstract][Full Text] [Related]
11. An efficient and general method for the synthesis of alpha,omega-difunctional reduced polypropionates by Zr-catalyzed asymmetric carboalumination: synthesis of the scyphostatin side chain.
Tan Z; Negishi E
Angew Chem Int Ed Engl; 2004 May; 43(22):2911-4. PubMed ID: 15170301
[No Abstract] [Full Text] [Related]
12. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
Mehta G; Modugu NR
J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
[TBL] [Abstract][Full Text] [Related]
13. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective reactions of a (-)-quinic acid-derived enone: application to the synthesis of the core of scyphostatin.
Murray LM; O'Brien P; Taylor RJ
Org Lett; 2003 May; 5(11):1943-6. PubMed ID: 12762692
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase.
Inoue M; Yokota W; Murugesh MG; Izuhara T; Katoh T
Angew Chem Int Ed Engl; 2004 Aug; 43(32):4207-9. PubMed ID: 15307088
[No Abstract] [Full Text] [Related]
16. A short and efficient route to novel scyphostatin analogues.
Runcie KA; Taylor RJ
Org Lett; 2001 Oct; 3(21):3237-9. PubMed ID: 11594803
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
18. Efficient synthesis of a 4,5-epoxy-2-cyclohexen-1-one derivative bearing a spirolactone via a Diels-Alder reaction with high pi-facial selectivity: a synthetic study towards scyphostatin.
Takagi R; Miyanaga W; Tamura Y; Ohkata K
Chem Commun (Camb); 2002 Sep; (18):2096-7. PubMed ID: 12357795
[TBL] [Abstract][Full Text] [Related]
19. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.
Wascholowski V; Giannis A; Pitsinos EN
ChemMedChem; 2006 Jul; 1(7):718-21. PubMed ID: 16902925
[No Abstract] [Full Text] [Related]
20. Synthesis of a 4,5-epoxy-2-cyclohexen-1-one derivative via epoxide ring opening, 1,3-carbonyl transposition and epoxide ring regeneration: a synthetic study on a scyphostatin analogue.
Takagi R; Tojo K; Iwata M; Ohkata K
Org Biomol Chem; 2005 May; 3(10):2031-6. PubMed ID: 15889188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
